Cardiogenic Shock Management in STEMI Patients: Contemporary Strategies, Clinical Outcomes, and Future Perspectives

doi:N/A

Bangaldesh Journal of Cardivascular Medicine

2024, Volume 2, Issue 4 : 1-4

Research Article

Cardiogenic Shock Management in STEMI Patients: Contemporary Strategies, Clinical Outcomes, and Future Perspectives

Michael J. Harrison

Sarah K. Ahmed

David L. Thompson

Department of Interventional Cardiology, Global Heart Institute, Boston, USA

Department of Cardiovascular Medicine, International Cardiac Research Centre, London, UK

Department of Critical Care Cardiology, European Institute of Cardiovascular Sciences, Berlin, Germany

Abstract

Cardiogenic shock (CS) remains the leading cause of mortality among patients presenting with ST-segment elevation myocardial infarction (STEMI). Despite significant advances in reperfusion therapy, pharmacological management, and mechanical circulatory support, cardiogenic shock continues to be associated with mortality rates ranging from 30% to 50%. Prompt recognition, early revascularization, hemodynamic stabilization, and multidisciplinary management are critical for improving outcomes. This review evaluates the epidemiology, pathophysiology, diagnosis, treatment strategies, mechanical support devices, prognostic factors, and future directions in cardiogenic shock management among STEMI patients. An integrated management framework is proposed to optimize clinical outcomes and reduce mortality.

Keywords

Cardiogenic Shock

STEMI

Acute Myocardial Infarction

Primary PCI

Mechanical Circulatory Support

Revascularization

Hemodynamic Support

Critical Care Cardiology

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

Bangladesh J. Cardiovasc. Med. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.

Recommended Articles

Antiplatelet Resistance in Acute Coronary Syndrome Patients: Mechanisms, Clinical Implications, and Management Strategies

Farhan A. Siddiqui,

Sophia L. Bennett,

Michael J. Carter,

Emily R. Thompson

1-7

Outcomes of Percutaneous Closure of Ventricular Septal Defects

Alexander R. Thompson,

Priya Menon,

Samuel K. Ibrahim,

Elena V. Petrova